A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
Clinical trial NCT01897116 · COMPLETED
Trial details
- NCT number
- NCT01897116
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-07-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.